e-learning
resources
Berlin 2001
Monday 24.09.2001
Pathophysiology of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of obstructive sleep apnea and the cytotoxic potential in peripheral blood lymphocytes
R. Staats, F. Gruner, S. Sorichter, W. Luttmann, H. Matthys, J. C. Virchow (Freiburg, Germany)
Source:
Annual Congress 2001 - Pathophysiology of OSA
Session:
Pathophysiology of OSA
Session type:
Poster Discussion
Number:
2218
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Staats, F. Gruner, S. Sorichter, W. Luttmann, H. Matthys, J. C. Virchow (Freiburg, Germany). Treatment of obstructive sleep apnea and the cytotoxic potential in peripheral blood lymphocytes. Eur Respir J 2001; 16: Suppl. 31, 2218
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Related content which might interest you:
Activated CD8 T-lymphocytes in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 820-828
Year: 2005
Monocytes inhibit NK activity
via
TGF-ß in patients with obstructive sleep apnoea
Source: Eur Respir J, 49 (6) 1602456; 10.1183/13993003.02456-2016
Year: 2017
The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
Decreased circulating endothelial progenitor cells in obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea
Source: Eur Respir J 2009; 33: 1077-1084
Year: 2009
Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive airway pressure treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008
Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Titration of continuous positive airway pressure in Chinese patients with obstructive sleep apnea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013
Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017
Effect of CPAP therapy on neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with obstructive sleep apnea.
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients
Source: Eur Respir J 2004; 23: 255-262
Year: 2004
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
Source: Eur Respir J 2009; 33: 574-580
Year: 2009
Effect of nCPAP therapy on inflammatory cell counts in pharyngeal lavage of patients with obstructive sleep apnea
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Regional cerebral blood flow in patients with obstructive sleep apnoea syndrome after continuous positive airway pressure therapy
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Continuous positive airway pressure in patients with obstructive sleep apnea: Age-dependent adherence
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Effects of treatments with nCPAP on cerebral blood flow velocity in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea
Source: Eur Respir J 2013; 42: 863-866
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept